Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) | PAR-22-161 | NCI | Through this funding opportunity announcement, the National Cancer Institute (NCI) solicits applications to Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts PAR. This… More | ||
| Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases | NOT-CA-20-045 | NCI | Notice Special Interest NOSI): Advancing Cancer Data Repositories Knowledgebases Notice Number: NOT-CA-20-045 Key Dates Release Date: April 09, 2020 First Available Due Date: September 25, 2020… More | ||
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | RFA-CA-22-006 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The… More | ||
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) | PAR-19-360 | NCI | This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent… More | ||
| Notice of Correction to the Specific Research Objectives for PA-16-175 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)" | NOT-CA-18-057 | NCI | N/A | Notice Correction the Specific Research Objectives PA-16-175 " Exploratory Grants Cancer Epidemiology Genomics Research R21)" Notice Number: NOT-CA-18-057 Key Dates Release Date: March… More | |
| Notice of Clarification to PAR-18-841, "Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)" | NOT-CA-19-064 | NCI | N/A | Notice Clarification PAR-18-841, Oncology Co-Clinical Imaging Research Resources Encourage Consensus Quantitative Imaging Methods Precision Medicine U24 - Clinical Trial Optional)" Notice… More | |
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | RFA-CA-22-040 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Biomarker Characterization Centers (BCCs), one of the three scientific units of the Early Detection Research… More | ||
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) | PAR-22-131 | NCI | This Funding Opportunity Announcement (FOA) will support the development of state-of-the-art projects that integrate imaging, biomarkers, digital pathomics, glycomics, metabolomics, other omic… More | ||
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-22-188 | NCI | This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based… More | ||
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | PAR-21-190 | NCI | This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on… More |